Pyronaridine

Pyronaridine is an antimalarial medication that is used to treat and prevent malaria. It is a combination of two active ingredients: artesunate and pyronaridine. Pyronaridine works by interfering with the growth and spread of the malaria parasites in the body. It is usually taken orally in combination with other antimalarials. It is usually taken once a day and may be combined with artemisinin-based combination therapies. It is available in tablet, capsule, and liquid forms. Pyronaridine is not recommended for use in children under the age of 6 months.

Pyronaridine is an antimalarial medication with a growing range of potential applications:

Malaria Treatment:

  • Primarily known for effectively treating malaria caused by Plasmodium falciparum and Plasmodium vivax parasites
  • Used in China for over 50 years, often under the trade name Malaridine
  • Now gaining interest globally due to its effectiveness against even drug-resistant malaria strains
  • Typically combined with artesunate (Pyramax) for a more powerful antimalarial effect

Mechanism of Action:

  • Works by interfering with the parasite's ability to synthesize heme, a molecule crucial for its survival within red blood cells

Other Potential Uses:

  • Early research suggests pyronaridine might have antiviral properties, including against Ebola and SARS-CoV-2 (the virus causing COVID-19)
  • It's also being studied as a potential treatment for cancer due to its effects on cell division

Important Considerations:

  • Pyronaridine is typically used in combination with other medications for malaria treatment
  • The combination of pyronaridine and artesunate is still under investigation for some applications like COVID-19 treatment
Anatomical Therapeutic Chemical Classification
P - Antiparasitic products, insecticides and repellents
P01 Antiprotozoals
P01B - Antimalarials
P01BF Artemisinin and derivatives, combinations
External Links